For 1HFY2022 ended June, earnings was down 45% y-o-y to $9.9 million. Revenue, meanwhile, was down 4% y-o-y to $90.9 million.
Revenue from its dental and medical clinics was up 5% y-o-y to $39.9 million while its smaller lab and supplies segment was down 67% y-o-y to $4.2 million.
The company plans to withhold an interim dividend for 2Q, as it plans to husband its internal resources for planned expansion ahead in a higher interest rate environment.
It now runs 104 clinics in Singapore and is in the midst of “a strategy of intensive organic growth” in Singapore. It has already shortlisted “appropriate locations” to open two new clinics in the subsequent quarters.
See also: Keppel Pacific Oak US REIT’s 1QFY2025 distributable income falls by 19.3% y-o-y to US$9.6 mil
It has been expanding in Malaysia too, with three new dental clinics in Cheras Selatan, Bahau and Segamat.
It is eyeing other Asean markets for growth as well.
Q&M shares closed at 48 cents, down 2.04%.
